Ethics application approved for preclinical study at Skåne University Hospital

NanoEcho will conduct a preclinical study led by Henrik Thorlacius, Professor of Surgery at Lund University and Chief Physician at Skåne University Hospital in Malmö, in which NanoEcho’s new instrument for detection of lymph nodes with cancer spread will be evaluated. The study will be carried out at Skåne University Hospital in Malmö and will include about 40 patients that will undergo he usual routine standard surgery. Once the cancer is removed from the patient, the surgical preparate will be examined with NanoEcho’s instrument. The result will then be compared with the pathologist’s final microscopic examination.

NanoEcho publishes investor letter

Read more about CEO Linda Persson and CTO Magnus Santesson as they tell more about their work to establish a strong company culture with a focus on delivery. “It is essential that we ourselves are as driven as our staff, and that we maintain the same commitment that we want to see from them,” says […]

We use cookies to enhance your experience on our website and analyze our traffic. By clicking ‘Accept,’ you consent to our use of cookies. You can learn more about the types of cookies we use and how to manage them in our privacy policy.